3,301 results match your criteria: "Benign Cardiac Tumors"
Gen Thorac Cardiovasc Surg Cases
December 2024
Department of Cardiovascular Surgery, Teikyo University Hospital, 2-21-1 Kaga, Itabashi-Ku, Tokyo, 173-8606, Japan.
Background: Cardiac myxoma rarely occurs in the right ventricle, and as is a benign disease, it rarely shows high positivity on 18F fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT).
Case Presentation: We present herein the case of a 77-year-old woman who was found to have a heart murmur during a routine health checkup. Further examination revealed a 27-mm tumor in the right ventricular outflow tract (RVOT) and moderate aortic valve stenosis.
Background: Primary cardiac tumors (PCT), such as myxoma, are rare and predominantly benign. Angiofibroma tumors are an extremely rare subtype of PCT, reported in less than ten cases. In this study, we presented a mixed tumor of myxoma and angiofibroma for the first time in the human heart.
View Article and Find Full Text PDFJACC Case Rep
December 2024
Department of Cardiac Surgery, University Hospital Bern, Bern, Switzerland.
Primary cardiac tumors are rare, most of them being benign. Most malignant cardiac tumors are sarcomas, with the most important therapeutic option being surgery, along with perioperative chemo- and radiotherapy. Here, we present a case of a 67-year-old female patient with no prior medical condition, who presented with primary cardiac sarcoma and extensive tumor growth in the pulmonary artery.
View Article and Find Full Text PDFArkh Patol
December 2024
Cancer Research Institute, branch of Tomsk National Research Medical Center, Tomsk, Russia.
Cardiac myxoma in its morphology is a typical benign tumor, meanwhile, the fact of its localization in the heart chamber, directly in the constant blood flow, largely determines the clinical behavior of this neoplasm, which is often manifested by the development of characteristics that formally determine the aggressive and even malignant nature of the course. Accordingly, the malignancy of cardiac myxoma is determined more by its clinical behavior (recurrence, multifocality of the lesion, the presence of mechanisms of spread similar to metastasis) rather than by its histological picture. In the structure of primary benign tumors of the heart, myxoma occupies a dominant position and its incidence is up to 85%.
View Article and Find Full Text PDFBMJ Case Rep
December 2024
Cardiology, Université de Fribourg Faculté de médecine, Fribourg, Switzerland
Phaeochromocytomas are rare catecholamine-secreting tumours, usually benign, originating from chromaffin cells of the adrenal glands. Their typical presentation includes the triad of headaches, sweating and tachycardia due to excessive catecholamine release. However, many patients do not exhibit all three symptoms, making diagnosis challenging.
View Article and Find Full Text PDFRev Fac Cien Med Univ Nac Cordoba
December 2024
Instituto Nacional de Neurología y Neurocirugía.
Introduction: Cardiac myxomas are the most common benign neoplasms of the heart, mainly located in the left atrium. The preferred treatment is the resection of the myxoma. This method not only prevents complications but also has a low recurrence rate.
View Article and Find Full Text PDFFront Cardiovasc Med
November 2024
Department of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Cureus
October 2024
Cardiovascular Medicine/Cardiology, College of Medicine, Kasr Alainy University, Cairo, EGY.
Cureus
October 2024
Medical Corps, Israel Defense Forces, Haifa, ISR.
US Cardiol
November 2024
Division of Cardiovascular Medicine, John T Milliken Department of Medicine, Barnes-Jewish Hospital, Washington University in St Louis St Louis, MO.
Int J Cardiol
February 2025
Pediatric Cardiology and Cardiac Arrhythmias and Syncope Unit, Bambino Gesù Children's Hospital, IRCSS, 00146 Rome, Italy; European Reference Network for Low Prevalence and Rare Disease of the Heart- ERN Guard Heart, Italy. Electronic address:
Cureus
October 2024
Department of Anatomical Sciences, William Carey University College of Osteopathic Medicine, Hattiesburg, USA.
Cureus
October 2024
Internal Medicine, Nishtar Medical University, Multan, PAK.
World J Pediatr Congenit Heart Surg
January 2025
Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
J Cardiothorac Surg
November 2024
University of Brescia, Brescia, Italy.
Kardiochir Torakochirurgia Pol
September 2024
Department of Cardiovascular Surgery and Transplantology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.
Cureus
October 2024
Radiodiagnosis, Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
J Surg Case Rep
October 2024
Department of Cardiology, Dabbous Cardiac Center, Adan Hospital, Kuwait City, Kuwait.
J Surg Case Rep
October 2024
Department of Cardiovascular Surgery, Isesaki Municipal Hospital, Isesaki, Gunma 372-0817, Japan.
Innovations (Phila)
December 2024
Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Centre, ON, Canada.
Am J Physiol Lung Cell Mol Physiol
January 2025
Department of Physiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, Larissa, Greece.
Int J Cardiol
January 2025
Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address:
Genome Biol
October 2024
Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ann Cardiol Angeiol (Paris)
December 2024
Département de Cardiologie, Hôpital Universitaire International CHEIKH KHALIFA, Casablanca, Maroc.